InvestorsHub Logo
Followers 46
Posts 4429
Boards Moderated 0
Alias Born 07/26/2010

Re: BesaoT35 post# 3516

Friday, 12/18/2020 9:09:15 AM

Friday, December 18, 2020 9:09:15 AM

Post# of 3705
11/17/2020 Form Type: 8-K...Palatin is advancing its COVID-19 development plan and is conducting all the required activities needed to file an IND and begin clinical studies with PL8177 as a treatment in COVID-19 patients. These activities will be completed in the fourth calendar quarter of 2020, allowing the Company to potentially file an IND with the FDA and initiate a clinical study of PL8177 for the treatment of COVID-19 patients early in the first calendar quarter of 2021.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News